Rdium. Circulation. 74:1124?136. 35. Kitagawa, K., et al. 1990. `Ischemic tolerance’ phenomenon located in

Rdium. Circulation. 74:1124?136. 35. Kitagawa, K., et al. 1990. `Ischemic tolerance’ phenomenon identified within the brain. Brain Res. 528:21?4. 36. Khaspekov, L., Shamloo, M., Victorov, I., and Wieloch, T. 1998. Sublethal in vitro glucose-oxygen deprivation protects cultured hippocampal neurons against a subsequent severe insult. Neuroreport. 9:1273?276. 37. Grabb, M.C., and Choi, D.W. 1999. Ischemic tolerance in murine cortical cell culture: critical part for NMDA receptors. J. Neurosci. 19:1657?662. 38. Chen, J., and Simon, R. 1997. Ischemic tolerance in the brain. Neurology. 48:306?11. 39. Wiegand, F., et al. 1999. Respiratory chain inhibition induces tolerance to focal cerebral ischemia. J. Cereb. Blood Flow Metab. 19:1229?237. 40. Barone, F.C., et al. 1998. Ischemic preconditioning and brain tolerance: temporal histological and functional outcomes, protein synthesis requirement, and interleukin-1 receptor antagonist and early gene expression. Stroke. 29:1937?950. 41. Douen, A.G., et al. 2000. Preconditioning with cortical spreading depression decreases intraischemic cerebral glutamate levels and downregulates excitatory amino acid transporters EAAT1 and EAAT2 from rat cerebral cortex plasma membranes.Formula of 53902-76-4 J. Neurochem. 75:812?18. 42. Zhao, Q., Pahlmark, K., Smith, M.L., and Siesjo, B.K. 1994. Delayed treatment with all the spin trap alpha-phenyl-N-tert-butyl nitrone (PBN) reduces infarct size following transient middle cerebral artery occlusionin rats. Acta Physiol. Scand. 152:349?50. 43. Goldberg, M. 2000. Washington University College of Medicine Net Stroke Clinical Trials Database. http://neuro.wustl.edu/stroke. 44. Du, C., Hu, R., Csernansky, C.A., Hsu, C.Y., and Choi, D.W. 1996. Incredibly delayed infarction immediately after mild focal cerebral ischemia: a role for apoptosis? J. Cereb. Blood Flow Metab. 16:195?01. 45. Nagayama, M., Zhang, F., and Iadecola, C. 1998. Delayed treatment with aminoguanidine decreases focal cerebral ischemic damage and enhances neurologic recovery in rats. J. Cereb. Blood Flow Metab. 18:1107?113. 46. Kew, J.N., Trube, G., and Kemp, J.A. 1996. A novel mechanism of activity-dependent NMDA receptor antagonism describes the impact of ifenprodil in rat cultured cortical neurones. J. Physiol. (Lond.) 497:761?72. 47. Auer, R.N. 1993. Calcium channel antagonists in cerebral ischemia: a assessment. Drugs Dev. 2:307?17. 48. Henkin, R.I., Patten, B.M., Re, P.K., and Bronzert, D.A. 1975. A syndrome of acute zinc loss. Cerebellar dysfunction, mental adjustments, anorexia, and taste and smell dysfunction. Arch. Neurol. 32:745?51. 49. Johnson, E.M., Jr., Koike, T., and Franklin, J. 1992. A “calcium set-point hypothesis” of neuronal dependence on neurotrophic factor.Iodo-PEG3-N3 Price Exp.PMID:24190482 Neurol. 115:163?66. 50. Du, C., et al. 1996. Additive neuroprotective effects of dextrorphan and cycloheximide in rats subjected to transient focal cerebral ischemia. Brain Res. 718:233?36. 51. Ma, J., Endres, M., and Moskowitz, M.A. 1998. Synergistic effects of caspase inhibitors and MK-801 in brain injury after transient focal cerebral ischaemia in mice. Br. J. Pharmacol. 124:756?62. 52. Seregi, A., Simmet, T., Schobert, A., and Hertting, G. 1990. Characterization of cysteinyl-leukotriene formation in main astroglial cell cultures. J. Pharm. Pharmacol. 42:191?93.The Journal of Clinical Investigation|September|Volume|Number
International Journal ofMolecular SciencesArticleCeftazidime-Avibactam (C/A) Resistant, Meropenem Sensitive KPC-Producing Klebsiella pneumoniae in ICU Setting.